perjeta

Generic: pertuzumab

Labeler: genentech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name perjeta
Generic Name pertuzumab
Labeler genentech, inc.
Dosage Form INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

pertuzumab 30 mg/mL

Manufacturer
Genentech, Inc.

Identifiers & Regulatory

Product NDC 50242-145
Product ID 50242-145_bef4af16-e063-40ce-a5b5-585d3311df2b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125409
Listing Expiration 2026-12-31
Marketing Start 2012-06-08

Pharmacologic Class

Established (EPC)
her2/neu receptor antagonist [epc]
Mechanism of Action
her2/neu/cerbb2 antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50242145
Hyphenated Format 50242-145

Supplemental Identifiers

RxCUI
1298948 1298953
UNII
K16AIQ8CTM
NUI
N0000175661 N0000020008

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name perjeta (source: ndc)
Generic Name pertuzumab (source: ndc)
Application Number BLA125409 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 30 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) / 14 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (1)

50242-145-01 1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) / 14 mL in 1 VIAL, SINGLE-USE

Ingredients (1)

pertuzumab (30 mg/mL)

Linked Drug Pages (1)

PERJETA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "bef4af16-e063-40ce-a5b5-585d3311df2b", "openfda": {"nui": ["N0000175661", "N0000020008"], "unii": ["K16AIQ8CTM"], "rxcui": ["1298948", "1298953"], "spl_set_id": ["17f85d17-ab71-4f5b-9fe3-0b8c822f69ff"], "pharm_class_epc": ["HER2/neu Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER2/Neu/cerbB2 Antagonists [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01)  / 14 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-145-01", "marketing_start_date": "20120608"}], "brand_name": "PERJETA", "product_id": "50242-145_bef4af16-e063-40ce-a5b5-585d3311df2b", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/neu Receptor Antagonist [EPC]"], "product_ndc": "50242-145", "generic_name": "Pertuzumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PERJETA", "active_ingredients": [{"name": "PERTUZUMAB", "strength": "30 mg/mL"}], "application_number": "BLA125409", "marketing_category": "BLA", "marketing_start_date": "20120608", "listing_expiration_date": "20261231"}